SCHEMBL18817938

SCHEMBL18817938

CC(=Nc1ccccc1)c1cc(Br)ccc1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSTA1 P08263 3/20 0.47
▸ CES2 O00748 1/20 0.46
▸ GALR3 O60755 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ CASP1 P29466 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ MEN1 O00255 3/20 0.44
▸ NPC1 O15118 3/20 0.44
▸ RAB9A P51151 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ OPRK1 P41145 1/20 0.44
▸ KDM4E B2RXH2 2/20 0.43
▸ PLAU P00749 1/20 0.43
▸ MAPT P10636 2/20 0.42
▸ GAA P10253 2/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ NOS3 P29474 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18817935 1.00 GSTA1 (0.47) GSTA1CES2GALR3CYP1A2CYP2C9
SCHEMBL18845626 0.85 MAOA (0.48) GSTA1CES2GALR3CYP1A2CYP2C9
SCHEMBL18817922 0.84 LMNA (0.50) GSTA1CES2GALR3CYP1A2CYP2C9
SCHEMBL18817903 0.84 MAPT (0.47) GSTA1CES2GALR3CYP1A2CYP2C9
SCHEMBL18817901 0.84 MAPT (0.47) GSTA1CES2GALR3CYP1A2CYP2C9
SCHEMBL18817925 0.84 LMNA (0.50) GSTA1CES2GALR3CYP1A2CYP2C9
SCHEMBL18817929 0.80 NOS1 (0.49) GSTA1CES2GALR3CYP1A2CYP2C9
SCHEMBL18817947 0.80 TMPRSS4 (0.46) GSTA1CES2GALR3CYP1A2CYP2C9
SCHEMBL18817944 0.80 TMPRSS4 (0.46) GSTA1CES2GALR3CYP1A2CYP2C9
SCHEMBL18817930 0.80 NOS1 (0.49) GSTA1CES2GALR3CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10155753-B2 4-substituted-2-(5-substituted-1H-indol-2-yl)phenol derivatives, methods for preparing the phenol derivatives and pharmaceutical compositions for inhibiting cell proliferation and migration including the phenol derivatives KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) 2018-12-18 — — US disclosed
US-20170129879-A1 4-SUBSTITUTED-2-(5-SUBSTITUTED-1H-INDOL-2-YL)PHENOL DERIVATIVES, METHODS FOR PREPARING THE PHENOL DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING CELL PROLIFERATION AND MIGRATION INCLUDING THE PHENOL DERIVATIVES KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) 2017-05-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10155753-B2 4-substituted-2-(5-substituted-1H-indol-2-yl)phenol derivatives, methods for preparing the phenol derivatives and pharmaceutical compositions for inhibiting cell proliferation and migration including the phenol derivatives MKI67, CCNI, CDK4 GSTA1 4340/4885CES2 1762/4885GALR3 825/4885
US-20170129879-A1 4-SUBSTITUTED-2-(5-SUBSTITUTED-1H-INDOL-2-YL)PHENOL DERIVATIVES, METHODS FOR PREPARING THE PHENOL DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING CELL PROLIFERATION AND MIGRATION INCLUDING THE PHENOL DERIVATIVES MKI67, CCNI, CDK4 GSTA1 4340/4885CES2 1762/4885GALR3 825/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback